09:37 AM EST - Medexus Pharmaceuticals : Recently completed a listing agreement with the provincial government of Quebec for Trecondyv® (treosulfan for injection). The Public Prescription Drug Insurance Plan of the Régie de l'Assurance Maladie du Québec, or RAMQ, will now reimburse eligible claims made for Trecondyv. Medexus Pharmaceuticals
shares T.MDP are trading unchanged at $2.35.
